Literature DB >> 708515

Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade.

G A Turini, H R Brunner, R K Ferguson, J L Rivier, H Gavras.   

Abstract

The role of the renin angiotensin system was evaluated in 18 normotensive patients with chronic congestive heart failure and in 5 controls. No correlation was observed between plasma renin activity and cardiac index. There was a significant inverse correlation between renin and pulmonary capillary wedge pressure (r = -0.61, P less than 0.01). Renin values of the patients appeared to be increased when compared with controls with similar left ventricular filling pressure. Specific angiotensin II inhibition by saralasin decreased arterial pressure in 8 out of 14 patients: their renin was significantly higher than that of the remaining 6 patients (P less than 0.01). The 2 patients with the lowest renin levels responded to saralasin with a blood pressure increase. Left ventricular filling pressure decreased in all but these latter 2 patients with either little change or an increase in stroke volume. Thus, renin levels appear to be increased in normotensive patients with congestive heart failure when related to left ventricular filling pressure. Renin via angiotensin II plays a role in the blood pressure control of many patients with congestive heart failure. In some patients angiotensin II blockade appears to improve cardiac function by unloading the left ventricle.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708515      PMCID: PMC483539          DOI: 10.1136/hrt.40.10.1134

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  33 in total

1.  The ventricular end-diastolic pressure. Appraisal of its value in the recognition of ventricular failure in man.

Authors:  E BRAUNWALD; J ROSS
Journal:  Am J Med       Date:  1963-02       Impact factor: 4.965

2.  VASCULAR EFFECTS OF ANGIOTENSIN AND NOREPINEPHRINE IN THE DOG, CAT, AND MONKEY.

Authors:  T E EMERSON; L B HINSHAW; C M BRAKE
Journal:  Am J Physiol       Date:  1965-02

3.  NATURE OF THE INOTROPIC ACTION OF ANGIOTENSIN ON VENTRICULAR MYOCARDIUM.

Authors:  J KOCH-WESER
Journal:  Circ Res       Date:  1965-03       Impact factor: 17.367

4.  The response of normal retinal blood vessels to angiotensin and noradrenaline.

Authors:  C T DOLLERY; D W HILL; J V HODGE
Journal:  J Physiol       Date:  1963-03       Impact factor: 5.182

Review 5.  The role of vasodilator therapy in heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

6.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents.

Authors:  M A Ondetti; B Rubin; D W Cushman
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

7.  The renin-angiotensin-aldosterone system in rabbits with congestive heart failure produced by aortic constriction.

Authors:  B J Morris; J O Davis; M L Zatzman; G M Williams
Journal:  Circ Res       Date:  1977-03       Impact factor: 17.367

8.  Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.

Authors:  D B Case; J M Wallace; H J Keim; M A Weber; J I Drayer; R P White; J E Sealey; J H Laragh
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

9.  Angiotensin II blockade in normal man: interaction of renin and sodium in maintaining blood pressure.

Authors:  L Posternak; H R Brunner; H Gavras; D B Brunner
Journal:  Kidney Int       Date:  1977-03       Impact factor: 10.612

10.  A specific orally active inhibitor of angiotensin-converting enzyme in man.

Authors:  R K Ferguson; G A Turini; H R Brunner; H Gavras; D N McKinstry
Journal:  Lancet       Date:  1977-04-09       Impact factor: 79.321

View more
  6 in total

1.  Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers.

Authors:  M D Schaller; J Nussberger; B Waeber; J P Bussien; G A Turini; H Brunner; H R Brunner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Changes in ventricular size and plasma renin activity after cardiac surgery in children.

Authors:  B D Bourgeois; I Oberhänsli; J C Rouge; L Paunier; B Friedli; M B Vallotton
Journal:  Br Heart J       Date:  1980-09

3.  Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.

Authors:  D N Sharpe; R J Coxon
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 4.  [Captopril in congestive heart failure (author's transl)].

Authors:  G Liebau
Journal:  Klin Wochenschr       Date:  1982-02-01

Review 5.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

Review 6.  Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.

Authors:  R J Cody
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.